Energy states in mitochondrial cardiomyopathy - In vivo functional imaging and L-arginine therapy

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2560-2561

  Ikawa, Masamichi ^a   Yoneda, Makoto ^a   Tanaka, Masashi ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; ACETIC ACID C 11; ARGININE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; CARDIOMYOPATHY; CITRIC ACID CYCLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; EDITORIAL; ENERGY METABOLISM; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HEART MUSCLE BLOOD FLOW; HUMAN; IN VIVO STUDY; MELAS SYNDROME; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; RESPIRATORY CHAIN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACETATES; ADULT; ARGININE; CARBON ISOTOPES; CARDIOMYOPATHIES; CITRIC ACID CYCLE; CORONARY CIRCULATION; ENERGY METABOLISM; FEMALE; HUMANS; MALE; MELAS SYNDROME; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 78649709700     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1062     Document Type: Editorial

References (15)

1. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-653.
2. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, et al. Cardiac involvement in mitochondrial diseases: A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995; 91: 955-961.
3. Vilarinho L, Santorelli FM, Rosas MJ, Tavares C, Melo-Pires M, DiMauro S. The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J Med Genet 1997; 34: 607-609.
4. Oldfors A, Tulinius M, Holme E, Kalimo H, Kristiansson B, Eriksson BO. Mitochondrial encephalomyopathy: A variant with heart failure and liver steatosis. Acta Neuropathol 1987; 74: 287-293.
5. Yoneda M, Miyatake T, Attardi G. Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol Cell Biol 1994; 14: 2699-2712.
6. Arakawa K, Kudo T, Ikawa M, Morikawa N, Kawai Y, Sahashi K, et al. Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion: C-11 acetate kinetics revealed by positron emission tomography. Circ J 2010; 74: 2702-2711.
7. Buxton DB, Nienaber CA, Luxen A, Ratib O, Hansen H, Phelps ME, et al. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Circulation 1989; 79: 134-142.
8. Wu YW, Naya M, Tsukamoto T, Komatsu H, Morita K, Yoshinaga K, et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J 2008; 72: 786-792.
9. 99mTc-MIBI mismatch. Mitochondrion 2007; 7: 164-170.
10. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
11. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methylbranched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822.
12. Ikawa M, Okazawa H, Arakawa K, Kudo T, Kimura H, Fujibayashi Y, et al. PET imaging of redox and energy states in stroke-like episodes of MELAS. Mitochondrion 2009; 9: 144-148.
13. Tsujikawa T, Yoneda M, Shimizu Y, Uematsu H, Toyooka M, Ikawa M, et al. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev 2010; 32: 143-149.
14. Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Tanabe Y, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005; 64: 710-712.
15. Koga Y, Akita Y, Junko N, Yatsuga S, Povalko N, Fukiyama R, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 2006; 66: 1766-1769.